About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
330 genotypes with 614 annotations displayed of selected term and subterms
Searched Term: abnormal neuroendocrine gland morphology
Allelic Composition
(Genetic Background)		 Annotated Term Reference
4933434E20Riktm1a(EUCOMM)Wtsi/4933434E20Riktm1a(EUCOMM)Wtsi
(C57BL/6N-4933434E20Riktm1a(EUCOMM)Wtsi/Wtsi) 		abnormal pineal gland morphology J:239583
Actn4tm1a(EUCOMM)Wtsi/Actn4tm1a(EUCOMM)Wtsi
(C57BL/6N-Actn4tm1a(EUCOMM)Wtsi/Wtsi) 		multiple persisting craniopharyngeal ducts J:239583
Adamts3tm1b(KOMP)Wtsi/Adamts3tm1b(KOMP)Wtsi
(C57BL/6N-Adamts3tm1b(KOMP)Wtsi/Wtsi) 		abnormal adenohypophysis morphology J:239583
multiple persisting craniopharyngeal ducts J:239583
AipGt(RRI002)Byg/Aip+
(involves: 129P2/OlaHsd * C57BL/6) 		increased pituitary adenoma incidence J:165349
increased prolactinoma incidence J:165349
Alktm1.1Rhp/Alktm1.1Rhp
(involves: 129 * C57BL/6N) 		decreased gonadotropin-releasing hormone neuron number J:226955
am/am
(involves: 101 * CBA) 		abnormal Rathke's pouch development J:6435
Anxa1tm1Rjf/Anxa1tm1Rjf
(involves: 129 * C57BL) 		abnormal corticotroph morphology J:135972
abnormal folliculo-stellate cell morphology J:135972
abnormal gonadotroph morphology J:135972
abnormal lactotroph morphology J:135972
abnormal somatotroph morphology J:135972
decreased corticotroph cell size J:135972
Arnt2tm1Yfk/Arnt2tm1Yfk
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal neurohypophysis morphology J:74118
Ascl1tm1And/Ascl1+
(involves: 129) 		decreased solitary pulmonary neuroendocrine cell number J:64088
Ascl1tm1And/Ascl1tm1And
(involves: 129) 		absent solitary pulmonary neuroendocrine cells J:64088, J:113000
Atcayji/Atcayji
(Not Specified) 		abnormal adenohypophysis morphology J:14903
Atg5tm1Nmz/Atg5tm1Nmz
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal adenohypophysis morphology J:110050
Atp11atm1a(KOMP)Wtsi/Atp11atm1a(KOMP)Wtsi
(C57BL/6N-Atp11atm1a(KOMP)Wtsi/Wtsi) 		abnormal adenohypophysis morphology J:239583
multiple persisting craniopharyngeal ducts J:239583
B4galt1tm1Shur/B4galt1tm1Shur
(involves: 129S7/SvEvBrd * C57BL/6J) 		abnormal adenohypophysis development J:37846
small adenohypophysis J:37846
B9d2tm1a(EUCOMM)Wtsi/B9d2tm1a(EUCOMM)Wtsi
(C57BL/6N-B9d2tm1a(EUCOMM)Wtsi/Wtsi) 		abnormal adenohypophysis morphology J:239583
abnormal neurohypophysis morphology J:239583
absent adenohypophysis J:239583
Bbs5tm1a(EUCOMM)Wtsi/Bbs5tm1a(EUCOMM)Wtsi
(C57BL/6-Bbs5tm1a(EUCOMM)Wtsi) 		abnormal pituitary gland morphology J:307098
small pituitary gland J:307098
Bmp4tm1Blh/Bmp4tm1Blh
(involves: 129S2/SvPas * Black Swiss) 		absent Rathke's pouch J:50517
Bmpr1atm1Bhr/Bmpr1atm2.1Bhr
Tg(Cga-cre)3Sac/0
(involves: 129S7/SvEvBrd * C57BL/6 * SJL) 		abnormal pituitary gland development J:121318
abnormal Rathke's pouch development J:121318
Braftm1Sva/Braftm1.1Sva
Tg(Nes-cre)1Kln/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		abnormal adenohypophysis morphology J:121660
small adenohypophysis J:121660
Braftm1Wds/Braftm1.1Wds
Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL) 		abnormal adenohypophysis morphology J:121660
small adenohypophysis J:121660
Brd2em1(IMPC)Wtsi/Brd2em1(IMPC)Wtsi
(C57BL/6N-Brd2em1(IMPC)Wtsi/WtsiIeg) 		abnormal adenohypophysis morphology J:239583
abnormal pineal gland morphology J:239583
Brip1Gt(RRI409)Byg/Brip1Gt(RRI409)Byg
(involves: 129P2/OlaHsd) 		increased pituitary adenoma incidence J:227115
Cacna2d2du-td/Cacna2d2du-td
(involves: DBA/2J) 		abnormal pituitary gland morphology J:12166
absent lactotrophs J:5596
Cacnb4lh/Cacnb4lh
(BALB/cGn-Cacnb4lh) 		pituitary gland hyperplasia J:12166
Capza2tm1b(KOMP)Wtsi/Capza2tm1b(KOMP)Wtsi
(C57BL/6N-Capza2tm1b(KOMP)Wtsi/Wtsi) 		multiple persisting craniopharyngeal ducts J:239583
Ccnd1tm1Dsn/Ccnd1tm1Dsn
Cdkn1btm1Mlf/Cdkn1btm1Mlf
(involves: 129 * C57BL/6) 		increased pituitary adenoma incidence J:66707
Cdk4tm1.1Bbd/Cdk4+
Krastm1Bbd/Kras+
Tg(CMV-cre)1Cgn/?
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ * C57BL/6) 		increased pituitary adenoma incidence J:86101
Cdk4tm1Kiyo/Cdk4tm1Kiyo
(involves: 129S1/Sv) 		adenohypophysis hypoplasia J:111333
decreased lactotroph cell number J:111333
Cdk4tm1Kiyo/Cdk4tm1Kiyo
Lin9tm1Orc/Lin9tm1Orc
(involves: 129S1/Sv) 		adenohypophysis hypoplasia J:111333
Cdkn1btm1Ako/Cdkn1btm1Ako
(involves: 129S1/Sv * C57BL/6) 		abnormal pituitary intermediate lobe morphology J:50053
increased pituitary gland tumor incidence J:50053
pituitary intermediate lobe hyperplasia J:50053, J:33401
Cdkn1btm1Ako/Cdkn1btm1Ako
Cdkn2ctm1Yxi/Cdkn2ctm1Yxi
(involves: 129/Sv * 129S1/Sv * C57BL/6 * DBA/2) 		enlarged pituitary gland J:50053
increased pituitary adenoma incidence J:50053
pituitary intermediate lobe hyperplasia J:50053
Cdkn1btm1Ako/Cdkn1btm1Ako
Men1tm1.1Ctre/Men1+
(involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6) 		increased pituitary gland tumor incidence J:120835
Cdkn1btm1Kin/Cdkn1btm1Kin
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal pituitary intermediate lobe morphology J:33402
increased pituitary adenoma incidence J:33402
increased pituitary gland weight J:33402
pituitary intermediate lobe hyperplasia J:33402
Cdkn1btm1Mlf/Cdkn1btm1Mlf
(involves: 129S4/SvJaeSor * C57BL/6J) 		enlarged pituitary gland J:33400
increased pituitary adenoma incidence J:33400
pituitary gland hyperplasia J:33400
Cdkn1btm2Mlf/Cdkn1btm2Mlf
Tg(Pomc1-cre)1Mlf/0
(involves: 129S4/SvJaeSor) 		increased pituitary gland tumor incidence J:107588
Cdkn1btm3Mlf/Cdkn1btm3Mlf
(involves: 129S4/SvJaeSor) 		increased pituitary gland tumor incidence J:107588
Cdkn2btm1Bbd/Cdkn2btm1Bbd
Cdkn2ctm1Bbd/Cdkn2ctm1Bbd
(involves: 129S1/Sv * C57BL/6) 		increased pituitary adenoma incidence J:63299
Cdkn2ctm1Bbd/Cdkn2ctm1Bbd
(involves: 129S1/Sv * C57BL/6) 		increased pituitary adenoma incidence J:63299
pituitary gland hyperplasia J:63299
Cdkn2ctm1Bbd/Cdkn2ctm1Bbd
Cdkn2dtm1Maro/Cdkn2dtm1Maro
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6) 		increased pituitary adenoma incidence J:68829
Cdkn2ctm1Yxi/Cdkn2ctm1Yxi
(involves: 129/Sv * C57BL/6 * DBA/2) 		abnormal pituitary intermediate lobe morphology J:50053
enlarged pituitary gland J:50053
increased pituitary adenoma incidence J:50053
pituitary gland hyperplasia J:50053
Cgatm1Sac/Cgatm1Sac
(involves: 129S2/SvPas * C57BL/6J) 		absent lactotrophs J:28450
decreased lactotroph cell number J:28450
decreased somatotroph cell number J:28450
increased thyrotroph cell number J:28450
Chd7Gt(S20-7E1)Sor/Chd7+
(129S1.129S4(B6)-Chd7Gt(S20-7E1)Sor) 		abnormal neurohypophysis median eminence morphology J:174086
decreased gonadotropin-releasing hormone neuron number J:174086
Chd7Gt(S20-7E1)Sor/Chd7Gt(S20-7E1)Sor
(involves: 129S1/SvImJ * 129S4/SvJae * C57BL/6J) 		Rathke's pouch hypoplasia J:119812
Chd7Whi/Chd7+
(C3HeB/FeJ-Chd7Whi) 		abnormal neurohypophysis median eminence morphology J:161880
decreased gonadotropin-releasing hormone neuron number J:161880
Chgbtm1Ribo/Chgbtm1Ribo
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal adrenal chromaffin cell morphology J:157697
Chtoptm1a(EUCOMM)Wtsi/Chtoptm1a(EUCOMM)Wtsi
(C57BL/6N-Chtoptm1a(EUCOMM)Wtsi/Wtsi) 		abnormal adenohypophysis morphology J:239583
abnormal neurohypophysis morphology J:239583
abnormal pineal gland morphology J:239583
Cir1tm3a(KOMP)Wtsi/Cir1tm3a(KOMP)Wtsi
(C57BL/6N-Cir1tm3a(KOMP)Wtsi/Wtsi) 		multiple persisting craniopharyngeal ducts J:239583
Cmiptm1a(EUCOMM)Wtsi/Cmiptm1a(EUCOMM)Wtsi
(C57BL/6N-Cmiptm1a(EUCOMM)Wtsi/Wtsi) 		multiple persisting craniopharyngeal ducts J:239583
Coro1ctm1a(KOMP)Wtsi/Coro1ctm1a(KOMP)Wtsi
(C57BL/6N-Coro1ctm1a(KOMP)Wtsi/Wtsi) 		multiple persisting craniopharyngeal ducts J:239583
Crhtm1Maj/Crhtm1Maj
(involves: 129S2/SvPas * C57BL/6) 		abnormal solitary pulmonary neuroendocrine cell morphology J:53721
Csf2tm1Mlg/Csf2tm1Mlg
Ifngtm1Ts/Ifngtm1Ts
Il3tm1Glli/Il3tm1Glli
(B6.129S-Csf2tm1Mlg Il3tm1Glli Ifngtm1TsIfngtm1Ts) 		increased pituitary adenoma incidence J:145518
Ctnnb1tm1Mmt/Ctnnb1+
Sox2tm1.1(cre/ERT2)Jpmb/Sox2+
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6) 		abnormal adenohypophysis morphology J:201265
increased pituitary gland tumor incidence J:201265
Ctnnb1tm1Mmt/Ctnnb1tm1Mmt
Tg(Pitx1-cre)7Rsd/0
(involves: 129X1/SvJ * BALB/c * C57BL/6) 		absent pituitary gland J:114817
Ctnnb1tm2Kem/Ctnnb1tm2Kem
Tg(Pitx1-cre)7Rsd/0
(involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6) 		abnormal adenohypophysis morphology J:114817
absent lactotrophs J:114817
absent somatotrophs J:114817
absent thyrotrophs J:114817
decreased gonadotroph cell number J:114817
increased corticotroph cell number J:114817
small adenohypophysis J:114817
Cul9tm1.2Yxi/Cul9+
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		increased pituitary gland tumor incidence J:170976
Cul9tm1.2Yxi/Cul9tm1.2Yxi
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		increased pituitary gland tumor incidence J:170976
Cycstm1Mak/Cycstm1Mak
(involves: C57BL/6) 		abnormal pituitary gland morphology J:98949
Cyp11a1tm1.1Bcc/Cyp11a1tm1.1Bcc
(B6.129(FVB)-Cyp11a1tm1.1Bcc) 		absent adrenal chromaffin cells J:191801
Cyp11b1tm1Chjk/Cyp11b1tm1Chjk
(involves: 129P2/OlaHsd * C57BL/6J) 		pituitary gland hyperplasia J:147610
Ddr2slie/Ddr2slie
(BKSChpLt.Cg-Tg(Ins2-Cpe)1Lt Cpefat/LtJng) 		small pituitary gland J:134371
Del(2Duoxa2-Duoxa1)1Sref/Del(2Duoxa2-Duoxa1)1Sref
(involves: 129S6/SvEvTac * C57BL/6J) 		enlarged adenohypophysis J:205165
Dhx35tm1b(EUCOMM)Wtsi/Dhx35tm1b(EUCOMM)Wtsi
(C57BL/6N-Dhx35tm1b(EUCOMM)Wtsi/Wtsi) 		abnormal adenohypophysis morphology J:239583
Disp1icb/Disp1tm1Amc
(involves: 129X1/SvJ * C57BL/6J) 		absent pituitary gland J:92058
Disp1tm1Amc/Disp1tm1Amc
(involves: 129X1/SvJ) 		pituitary gland hypoplasia J:92058
Dmdmdx/Dmdmdx
(C57BL/10ScSn-Dmdmdx) 		abnormal corticotroph morphology J:18080
increased somatotroph cell size J:18080
Dmxl2tm1a(EUCOMM)Wtsi/Dmxl2tm1a(EUCOMM)Wtsi
(C57BL/6N-Atm1Brd Dmxl2tm1a(EUCOMM)Wtsi/WtsiH) 		multiple persisting craniopharyngeal ducts J:239583
Dmxl2tm1c(EUCOMM)Wtsi/Dmxl2+
Tg(Nes-cre)1Atp/0
(involves: C57BL/6N * FVB/N) 		decreased gonadotropin-releasing hormone neuron number J:217623
Drd2tm1.1Mrub/Drd2tm1.1Mrub
Tg(Nes-cre)1Kln/?
(involves: 129S4/SvJae * C57BL/6 * SJL) 		decreased somatotroph cell number J:194227
Drd2tm1Ebo/Drd2tm1Ebo
(involves: 129S2/SvPas * C57BL/6) 		abnormal melanotroph morphology J:110599
adenohypophysis hyperplasia J:41857
decreased lactotroph cell size J:41857
decreased somatotroph cell number J:41857
enlarged pituitary gland J:41857
increased lactotroph cell number J:41857
increased pituitary adenoma incidence J:41857
increased thyrotroph cell number J:41857
pituitary gland hyperplasia J:41857
pituitary intermediate lobe hyperplasia J:110599, J:41857
Drd2tm1Low/Drd2tm1Low
(either: B6.129S2-Drd2tm1Low or (involves: 129S2/SvPas * C57BL/6)) 		abnormal adenohypophysis morphology J:41858
abnormal pituitary gland morphology J:41858
adenohypophysis hyperplasia J:41858
adenohypophysis hypertrophy J:41858
adenohypophysis peliosis J:41858
decreased gonadotroph cell number J:41858
enlarged pituitary gland J:41858
increased lactotroph cell number J:41858
increased pituitary gland weight J:41858
Drd2tm1Mok/Drd2tm1Mok
(involves: 129S/SvEv * C57BL/6J * DBA/2J) 		enlarged pituitary intermediate lobe J:97838
Duox2thyd/Duox2thyd
(B6(129)-Duox2thyd/J) 		abnormal adenohypophysis morphology J:121821
dwt/dwt
(TAIII) 		decreased somatotroph cell number J:14660
decreased somatotroph cell size J:14660
E2f1tm1Njd/E2f1tm1Njd
Rb1tm1Tyj/Rb1+
(either: 129S2/SvPas or (involves: 129S2/SvPas * C57BL/6)) 		increased pituitary gland tumor incidence J:47108
E2f4tm1Lees/E2f4+
Rb1tm1Tyj/Rb1+
(involves: 129S2/SvPas * C57BL/6) 		increased pituitary gland tumor incidence J:81082
Egln3tm1Pjr/Egln3tm1Pjr
(involves: 129S/SvEv * Swiss) 		abnormal adrenal chromaffin cell morphology J:136034
Egr1tm1Pch/Egr1tm1Pch
(involves: 129S2/SvPas * C57BL/6J) 		adenohypophysis hypoplasia J:45064
decreased somatotroph cell number J:45064
Emx1tm1(cre)Ito/Emx1+
Hes1tm1Fgu/Hes1tm1Hojo
Hes5tm1Fgu/Hes5tm1Fgu
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ) 		abnormal neurohypophysis morphology J:121843
abnormal pituitary diverticulum morphology J:121843
abnormal pituitary gland development J:121843
abnormal pituitary gland morphology J:121843
abnormal pituitary infundibular stalk morphology J:121843
absent pituitary intermediate lobe J:121843
increased somatotroph cell number J:121843
pituitary gland hypoplasia J:121843
Emx2tm1Sia/Emx2tm1Sia
Otx2tm1Sia/Otx2+
(involves: C57BL/6 * CBA) 		abnormal adenohypophysis morphology J:70745
Erbb3tm1Gne/Erbb3tm1Gne
(involves: 129S2/SvPas * C57BL/6) 		absent adrenergic chromaffin cells J:45302
Erbb3tm2Cbm/Erbb3tm2Cbm
(involves: 129P2/OlaHsd) 		absent adrenergic chromaffin cells J:48515
Esr1tm1.2Awo/Esr1tm1.2Awo
Tg(Cga-cre)1Awo/0
(involves: C57BL/6 * SJL) 		decreased gonadotroph cell number J:152925
Esr1tm1.2Mma/Esr1tm1.2Mma
Tg(Cyp17a1-icre)AJako/0
(involves: 129S2/SvPas * C57BL/6 * SJL) 		increased gonadotroph cell number J:151908
Esr1tm1Ksk/Esr1tm1Ksk
(involves: 129P2/OlaHsd) 		decreased lactotroph cell number J:40607
Eya1tm1Rilm/Eya1tm1Rilm
Six1tm1Rsd/Six1tm1Rsd
(involves: 129S1/Sv * 129X1/SvJ) 		pituitary gland hypoplasia J:86619
small pituitary gland J:86619
Fbn1tm1Rmz/Fbn1tm1Rmz
(involves: 129S4/SvJae * C57BL/6J) 		increased solitary pulmonary neuroendocrine cell number J:137934
Fgf8tm1.1Mrt/Fgf8tm1.2Mrt
(involves: 129P2/OlaHsd) 		abnormal pituitary gland morphology J:178252
Fgf10tm1Ska/Fgf10tm1Ska
(involves: C57BL/6 * CBA) 		abnormal neurohypophysis development J:114183
abnormal Rathke's pouch apoptosis J:114183
absent adenohypophysis J:114183
absent pituitary gland J:114183
absent Rathke's pouch J:114183
Fgfr2tm1.1Dsn/Fgfr2tm1.1Dsn
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal pituitary gland development J:59285
abnormal Rathke's pouch apoptosis J:59285
abnormal Rathke's pouch development J:59285
absent adenohypophysis J:59285
absent Rathke's pouch J:59285
Fgfr2tm3Dsn/Fgfr2tm3Dsn
(involves: 129P2/OlaHsd * C57BL/6) 		absent adenohypophysis J:67731
Foxc1ch/Foxc1ch
(involves: CBA * STOCK Tyrc f) 		abnormal pituitary diverticulum morphology J:5191
abnormal pituitary gland development J:75733
Foxo3tm1.1Rdp/Foxo3+
Foxo4tm1.1Rdp/Foxo4tm1.1Rdp
(involves: 129S1/Sv * 129S6/SvEvTac * FVB/N) 		increased pituitary adenoma incidence J:118179
Foxo3tm1.1Rdp/Foxo3tm1.1Rdp
(involves: 129S6/SvEvTac * FVB/N) 		increased prolactinoma incidence J:118179
Foxo3tm1.1Rdp/Foxo3tm1.1Rdp
Foxo4tm1.1Rdp/Foxo4tm1.1Rdp
(involves: 129S1/Sv * 129S6/SvEvTac * FVB/N) 		increased pituitary adenoma incidence J:118179
Fshrtm1Saco/Fshrtm1Saco
(involves: C57BL/6) 		adenohypophysis hyperplasia J:50933
increased gonadotroph cell number J:50933
increased thyrotroph cell number J:50933
FuzGt(OSTGST001398)Lex/FuzGt(OSTGST001398)Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		abnormal pituitary diverticulum morphology J:177881
Galtm1Wyn/Galtm1Wyn
(129P2-Galtm1Wyn) 		decreased lactotroph cell number J:78046
Gata2tm1Sac/Gata2tm1Sac
Tg(Cga-cre)3Sac/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL) 		abnormal pituitary gland development J:108963
GhSma1/Gh+
(C3HeB/FeJ-GhSma1) 		abnormal adenohypophysis morphology J:89518
absent lactotrophs J:89518
absent somatotrophs J:89518
decreased pituitary gland weight J:89518
small adenohypophysis J:89518
small pituitary gland J:89518
GhSma1/GhSma1
(C3HeB/FeJ-GhSma1) 		abnormal adenohypophysis morphology J:89518
absent lactotrophs J:89518
absent somatotrophs J:89518
decreased pituitary gland weight J:89518
small adenohypophysis J:89518
small pituitary gland J:89518
Ghrtm1Jjk/Ghrtm1Jjk
(involves: 129P2/OlaHsd * BALB/c) 		decreased pituitary gland weight J:53777
Ghrhtm1Salv/Ghrhtm1Salv
(involves: 129 * C57BL/6) 		pituitary gland hypoplasia J:91828
Ghrhrlit/Ghrhrlit
(C57BL/6J-Ghrhrlit) 		abnormal somatotroph morphology J:7211
absent somatotroph secretory granules J:7211
decreased somatotroph cell number J:7211
decreased somatotroph cell size J:7211
decreased somatotroph secretory granule number J:7211
small pituitary gland J:5647
Gli1tm1Alj/Gli1tm1Alj
Gli2tm1Alj/Gli2tm1Alj
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		absent pituitary gland J:60986
Gli3Pdn/Gli3Pdn
(involves: Jcl:ICR) 		absent pineal gland J:17581
Gli3Xt/Gli3Xt
(involves: 101/H * C3H/HeH * CBA/H) 		absent pineal gland J:5049
Gsx1tm1Ssp/Gsx1tm1Ssp
(involves: 129P2/OlaHsd) 		decreased lactotroph cell number J:31764
decreased somatotroph cell number J:31764
small adenohypophysis J:31764
small pituitary gland J:31764
Gt(ROSA)26Sortm1(CAG-Bmi1,-EGFP)Nki/Gt(ROSA)26Sor+
Rb1tm2Brn/Rb1tm2Brn
Tg(Gfap-cre)2Brn/0
(either: (involves: 129 * 129P2/OlaHsd * FVB/N) or (involves: 129 * 129P2/OlaHsd * C57BL/6 * FVB/N)) 		increased pituitary gland tumor incidence J:187257
Gt(ROSA)26Sortm1(CAG-Bmi1,-EGFP)Nki/Gt(ROSA)26Sor+
Rb1tm2Brn/Rb1tm2Brn
Trp53tm1Brn/Trp53tm1Brn
Tg(Gfap-cre)2Brn/0
(either: (involves: 129 * 129P2/OlaHsd * FVB/N) or (involves: 129 * 129P2/OlaHsd * C57BL/6 * FVB/N)) 		increased pituitary gland tumor incidence J:187257
Gt(ROSA)26Sortm1(CAG-Bmi1,-EGFP)Nki/Gt(ROSA)26Sor+
Tg(Gfap-cre)2Brn/0
(either: (involves: 129P2/OlaHsd * FVB/N) or (involves: 129P2/OlaHsd * C57BL/6 * FVB/N)) 		increased pituitary gland tumor incidence J:187257
Gt(ROSA)26Sortm1(CAG-Foxo1*)Jcbr/Gt(ROSA)26Sor+
Pdpk1tm1Jcbr/Pdpk1tm1Jcbr
Tg(Pomc1-cre)16Lowl/0
(involves: C57BL/6 * FVB/N) 		decreased corticotroph cell number J:134336
Gt(ROSA)26Sortm1(DTA)Lky/Gt(ROSA)26Sor+
Tg(LHX3-cre)#Sjr/0
(involves: 129P2/OlaHsd * BALB/c * C3H * C57BL/6) 		abnormal adenohypophysis morphology J:211401
decreased gonadotroph cell number J:211401
Gt(ROSA)26Sortm1(HBEGF)Awai/Gt(ROSA)26Sor+
Tg(Gh1-cre)bKnmn/0
(involves: C57BL/6 * FVB/N) 		decreased somatotroph cell number J:169459
small adenohypophysis J:169459
Gt(ROSA)26Sortm1(sb11)Njen/Gt(ROSA)26Sor+
TgTn(sb-T2/Onc2)6113Njen/0
(involves: C3H * C57BL/6) 		pituitary gland hyperplasia J:102234
Gt(ROSA)26Sortm1Fia/Gt(ROSA)26Sor+
Nf1tm1Par/Nf1tm1Par
Tg(Fabp7-cre,-lacZ)3Gtm/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		small adenohypophysis J:138868
Gt(ROSA)26Sortm2(myc*T58A)Rcse/Gt(ROSA)26Sortm2(myc*T58A)Rcse
Tg(Wap-cre)11738Mam/0
(involves: 129 * C57BL/6 * SJL) 		increased pituitary gland tumor incidence J:169403
H13tm1b(KOMP)Wtsi/H13tm1b(KOMP)Wtsi
(C57BL/6N-H13tm1b(KOMP)Wtsi/Wtsi) 		multiple persisting craniopharyngeal ducts J:239583
HelqGt(RRF112)Byg/Helq+
(involves: 129P2/OlaHsd * C57BL/6) 		increased pituitary adenoma incidence J:206104
HelqGt(RRF112)Byg/HelqGt(RRF112)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		increased pituitary adenoma incidence J:206104
Hes1tm1Fgu/Hes1+
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		increased solitary pulmonary neuroendocrine cell number J:64088
Hes1tm1Fgu/Hes1tm1Fgu
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		increased solitary pulmonary neuroendocrine cell number J:64088
Hes1tm1Fgu/Hes1tm1Fgu
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal pituitary gland development J:121843
pituitary gland hypoplasia J:121843
Hesx1tm1Icar/Hesx1tm1Icar
(involves: 129P2/OlaHsd * C57BL/6) 		absent pituitary infundibular stalk J:47920
absent Rathke's pouch J:47920
bifurcated Rathke's pouch J:47920
small adenohypophysis J:47920
Hesx1tm2Jpmb/Hesx1tm2Jpmb
(involves: 129S/SvEv * C57BL/6J * FVB/N) 		abnormal adenohypophysis morphology J:142649
ectopic pituitary gland J:142649
Hesx1tm3Jpmb/Hesx1tm3Jpmb
(involves: 129S/SvEv * C57BL/6J * FVB/N) 		abnormal adenohypophysis morphology J:142649
abnormal pituitary gland morphology J:142649
abnormal Rathke's pouch development J:142649
ectopic adenohypophysis J:142649
ectopic pituitary gland J:142649
Hhextm1Rbe/Hhextm1Rbe
(involves: 129P2/OlaHsd * C57BL/6) 		absent Rathke's pouch J:62027
Hmx3/Hmx2tm3Tlu/Hmx3/Hmx2tm3Tlu
(either: (involves: 129) or (involves: 129 * C57BL/6J)) 		small adenohypophysis J:92940
small pituitary gland J:92940
Hmx3/Hmx2tm3Tlu/Hmx3/Hmx2tm3Tlu
(either: (involves: 129) or (involves: 129 * C57BL/6J)) 		small adenohypophysis J:92940
small pituitary gland J:92940
Hsd17b3tm1.2Mpo/Hsd17b3tm1.2Mpo
(involves: 129S6/SvEvTac * C57BL/6N * C57BL/6NCrl) 		decreased pituitary gland weight J:301756
Igsf1tm1Zuk/Y
(either: (involves: 129S6/SvEv * 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6J)) 		abnormal pituitary gland morphology J:190867
Insm1tm1Cbm/Insm1tm1Cbm
(involves: 129P2/OlaHsd) 		abnormal pituitary gland development J:206319
absent somatotrophs J:206319
absent thyrotrophs J:206319
small pituitary gland J:206319
Irs2tm1Mfw/Irs2tm1Mfw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		decreased gonadotroph cell number J:64791
small pituitary gland J:64791
small pituitary intermediate lobe J:74303
Isl1tm1Tmj/Isl1tm1Tmj
(involves: 129S1/Sv) 		abnormal Rathke's pouch development J:50517
small Rathke's pouch J:50517
Kdm1atm1.1Rsd/Kdm1atm1.1Rsd
Tg(Pitx1-cre)7Rsd/0
(involves: BALB/c * C57BL/6) 		abnormal pituitary gland development J:121427
Kdm5atm1.1Kael/Kdm5a+
Rb1tm1Tyj/Rb1+
(involves: 129S2/SvPas * 129S6/SvEvTac * FVB/N) 		increased pituitary gland tumor incidence J:175625
Kdm5atm1.1Kael/Kdm5atm1.1Kael
Rb1tm1Tyj/Rb1+
(involves: 129S2/SvPas * 129S6/SvEvTac * FVB/N) 		increased pituitary gland tumor incidence J:175625
Kifbptm1a(KOMP)Wtsi/Kifbptm1a(KOMP)Wtsi
(C57BL/6N-Kifbptm1a(KOMP)Wtsi/Wtsi) 		abnormal adenohypophysis morphology J:239583
Klkl/Klkl
(either: C.Cg-Klkl or (involves: C3H/HeJ * C57BL/6J)) 		abnormal adenohypophysis morphology J:44109
abnormal gonadotroph morphology J:44109
decreased somatotroph cell size J:44109
decreased somatotroph secretory granule number J:44109
Lats1tm1Tx/Lats1tm1Tx
(involves: 129S2/SvPas * C57BL/6J) 		adenohypophysis hyperplasia J:52536
Leptm1.2Gvcao/Leptm1.2Gvcao
(involves: 129S4/SvJaeSor * FVB/NJ * FVB/NTac) 		decreased somatotroph cell number J:218720
Leprtm1.1Chua/Lepr+
Tg(Gh1-cre)bKnmn/0
(involves: 129 * C57BL/6 * FVB) 		decreased somatotroph cell number J:173444
Leprtm1.1Chua/Leprtm1.1Chua
Tg(Gh1-cre)bKnmn/0
(involves: 129 * C57BL/6 * FVB) 		decreased somatotroph cell number J:173444
Lhx3tm1(cre)Slp/Lhx3tm1(cre)Slp
(involves: 129S1/Sv) 		abnormal Rathke's pouch apoptosis J:119270
abnormal Rathke's pouch development J:119270
absent adenohypophysis J:119270
small pituitary intermediate lobe J:119270
Lhx3tm1.1Sjr/Lhx3tm1.1Sjr
(involves: 129S/SvEv * C57BL/6J * FVB/N) 		abnormal pituitary gland morphology J:169035
adenohypophysis hypoplasia J:169035
decreased gonadotroph cell number J:169035
decreased lactotroph cell number J:169035
Lhx3tm1Lmgd/Lhx3tm1Lmgd
(involves: 129S4/SvJae) 		abnormal corticotroph morphology J:33050
abnormal pituitary gland development J:33050
abnormal Rathke's pouch development J:33050
absent adenohypophysis J:33050, J:51420
absent lactotrophs J:33050
absent pituitary intermediate lobe J:33050, J:51420
absent somatotrophs J:33050
absent thyrotrophs J:33050
decreased gonadotroph cell number J:33050
Lhx4tm1Ssp/Lhx4tm1Ssp
(involves: 129S2/SvPas * CF-1) 		abnormal Rathke's pouch development J:79850
decreased gonadotroph cell number J:79850
small adenohypophysis J:79850
small Rathke's pouch J:79850
Lhx4tm1Ssp/Lhx4tm1Ssp
Prop1df/Prop1df
(involves: 129S2/SvPas * C57BL/6 * CF-1 * Goodale large mice * pink-eyed stock) 		abnormal Rathke's pouch apoptosis J:79850
abnormal Rathke's pouch development J:79850
absent adenohypophysis J:79850
absent gonadotrophs J:79850
small Rathke's pouch J:79850
Mark2Gt(pSABetageo)38Bss/Mark2Gt(pSABetageo)38Bss
(involves: 129S2/SvPas * MF1) 		small pituitary gland J:57958
Mbd5tm1.2Gxu/Mbd5tm1.2Gxu
(involves: 129S2/SvPas * C57BL/6J) 		small pituitary gland J:192212
Men1tm1.1Ctre/Men1+
(involves: 129S6/SvEvTac * FVB/N) 		increased pituitary adenohypophysis tumor incidence J:133299
Men1tm1.1Ctre/Men1+
(involves: 129S6/SvEvTac * C57BL/6) 		increased pituitary gland tumor incidence J:120835
Men1tm1.1Ctre/Men1+
Rb1tm1Tyj/Rb1+
(involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6J * FVB/N) 		increased pituitary adenohypophysis tumor incidence J:133299
increased pituitary melanotroph tumor incidence J:133299
Men1tm1.1Gfk/Men1+
(involves: 129T2/SvEms * C57BL/6) 		abnormal pituitary gland morphology J:116086
increased pituitary adenoma incidence J:116086
increased prolactinoma incidence J:116086
Men1tm1Ctre/Men1+
(either: (involves: 129S6/SvEvTac * FVB/N) or (involves: 129S6/SvEvTac * Black Swiss * FVB/N)) 		increased pituitary adenoma incidence J:67128
increased prolactinoma incidence J:67128
Men1tm1Gfk/Men1tm1Gfk
Tg(Ins2-cre)25Mgn/0
(involves: 129T2/SvEms * C57BL/6 * C57BL/6J * DBA) 		increased prolactinoma incidence J:89898
Men1tm1Rvt/Men1+
(involves: 129 * C57BL/6) 		increased pituitary adenohypophysis tumor incidence J:191261
increased pituitary gland tumor incidence J:191261
Men1tm1Zqw/Men1+
(involves: 129/Sv * 129P2/OlaHsd) 		enlarged pituitary gland J:85302
increased pituitary adenohypophysis tumor incidence J:85302
increased prolactinoma incidence J:85302
Men1tm2.1Gfk/Men1+
(involves: 129T2/SvEms * C57BL/6) 		abnormal pituitary gland morphology J:116086
increased pituitary adenoma incidence J:116086
Morc2aem1(IMPC)Wtsi/Morc2aem1(IMPC)Wtsi
(C57BL/6N-Morc2aem1(IMPC)Wtsi/WtsiOulu) 		abnormal pineal gland morphology J:239583
abnormal pituitary gland morphology J:239583
absent pituitary gland J:239583
Msh2tm1Whl/Msh2tm1Whl
Rb1tm1Brd/Rb1+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J) 		increased pituitary adenohypophysis tumor incidence J:79016
increased pituitary melanotroph tumor incidence J:79016
Msx1tm1Bero/Msx1tm1Bero
(B6.129P2-Msx1tm1Bero) 		abnormal subcommissural organ morphology J:84975
NbeaTg(GH1)240BNec/Nbea+
(involves: C57BL/6 * SJL) 		abnormal pituitary gland development J:128767
Ndst1tm1.1Grob/Ndst1tm1.1Grob
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		pituitary gland hypoplasia J:100425
Neurod1tm1Mjts/Neurod1tm1Mjts
(involves: 129X1/SvJ) 		decreased solitary pulmonary neuroendocrine cell number J:137934
Nf1tm1Par/Nf1tm1Par
H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		abnormal adrenergic chromaffin cell morphology J:80323
Nf1tm1Par/Nf1tm1Par
Tg(Fabp7-cre,-lacZ)3Gtm/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		abnormal pituitary gland development J:138868
abnormal pituitary gland morphology J:138868
small adenohypophysis J:138868
small pituitary gland J:138868
Nf1tm1Par/Nf1tm1Par
Tg(Mpz-cre)94Imeg/0
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal adrenergic chromaffin cell morphology J:80323
Nf1tm1Par/Nf1tm1Par
Tg(Pax3-cre)1Joe/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		abnormal adrenergic chromaffin cell morphology J:80323
Nf2tm2Gth/Nf2tm2Gth
Ptgdstm1.1(cre)Gvn/Ptgds+
(involves: 129P2/OlaHsd * FVB/N) 		increased pituitary adenoma incidence J:173718
Nkx2-1tm1Shk/Nkx2-1tm1Shk
(B6.129S4-Nkx2-1tm1Shk) 		absent pituitary gland J:169693
Nkx2-1tm1Shk/Nkx2-1tm1Shk
(involves: 129S4/SvJae) 		abnormal adenohypophysis development J:50517
abnormal Rathke's pouch apoptosis J:50517
abnormal Rathke's pouch development J:50517
absent pituitary gland J:30559
absent pituitary infundibular stalk J:50517
Nkx2-1tm2Rdl/Nkx2-1tm2Rdl
(B6.129-Nkx2-1tm2Rdl) 		abnormal pituitary gland development J:169693
abnormal Rathke's pouch development J:169693
absent infundibular recess of third ventricle J:169693
absent pituitary gland J:169693
Nogtm1Amc/Nogtm1Amc
(either: (involves: 129S1/Sv * CD-1) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)) 		abnormal pituitary gland development J:121318
abnormal Rathke's pouch apoptosis J:121318
abnormal Rathke's pouch development J:121318
absent adenohypophysis J:121318
absent pituitary gland J:121318
absent pituitary infundibular stalk J:121318
absent Rathke's pouch J:121318
Notch2tm3Grid/Notch2tm3Grid
Foxg1tm1(cre)Skm/Foxg1+
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6) 		small pituitary gland J:130929
Npattm1b(EUCOMM)Wtsi/Npattm1b(EUCOMM)Wtsi
(C57BL/6N-Npattm1b(EUCOMM)Wtsi/Wtsi) 		multiple persisting craniopharyngeal ducts J:239583
Npc1m1N/Npc1m1N
(involves: BALB/c) 		abnormal adenohypophysis morphology J:91430
adenohypophysis hypoplasia J:91430
decreased lactotroph cell number J:91430
Nr1h2tm1.1Gstr/Nr1h2tm1.1Gstr
Nr1h3tm1.1Gstr/Nr1h3tm1.1Gstr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal neurohypophysis median eminence morphology J:81790
Nr3c1tm1Gsc/Nr3c1tm1Gsc
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal adrenal chromaffin cell morphology J:27441
absent adrenergic chromaffin cells J:27441
Nr3c1tm1Gsc/Nr3c1tm1Gsc
(involves: 129P2/OlaHsd) 		abnormal adrenal chromaffin cell morphology J:54931
Nr3c1tm2.1Gsc/Nr3c1tm2.1Gsc
(involves: 129P2/OlaHsd) 		abnormal adrenal chromaffin cell morphology J:54931
Nr5a1tm1Enl/Nr5a1tm1Enl
(involves: 129S4/SvJae) 		abnormal pituitary gland morphology J:28971
decreased gonadotroph cell number J:28971
Nrp1tm1Hfu/Nrp1tm2Ddg
Tg(Tek-cre)1Ywa/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj * SJL) 		decreased gonadotropin-releasing hormone neuron number J:175836
Nsmftm1a(KOMP)Wtsi/Nsmftm1a(KOMP)Wtsi
(involves: C57BL/6N) 		decreased gonadotroph cell number J:222116
Olfm1tm1.1Lex/Olfm1tm1.1Lex
(involves: 129S/SvEvBrd * 129S4/SvJae) 		decreased gonadotropin-releasing hormone neuron number J:226939
Otptm1Tlu/Otptm1Tlu
(either: 129/Sv-Otptm1Tlu or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)) 		abnormal neurohypophysis median eminence morphology J:65759
abnormal neurohypophysis morphology J:65759
Otx2tm1Pas/Otx2+
(involves: C57BL/6 * FVB/N) 		abnormal gonadotroph morphology J:210118
decreased gonadotroph cell number J:210118
Otx2tm1Sia/Otx2+
(involves: C57BL/6 * CBA) 		abnormal adenohypophysis morphology J:29682
Otx2tm2(Otx1)Sia/Otx2tm2(Otx1)Sia
(involves: C57BL/6 * CBA) 		absent pituitary gland J:51989
Pax8tm1Pgr/Pax8tm1Pgr
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)) 		abnormal adenohypophysis morphology J:117324
decreased lactotroph cell number J:117324
decreased somatotroph cell number J:117324
increased thyrotroph cell number J:117324
Pdpk1tm1Jcbr/Pdpk1tm1Jcbr
Tg(Pomc1-cre)16Lowl/0
(involves: C57BL/6 * FVB/N) 		abnormal melanotroph morphology J:134336
decreased corticotroph cell number J:134336
Pdpk1tm1Maka/Pdpk1tm1Maka
Tg(CAG-cat,-lacZ)11Miya/0
Tg(Pomc1-cre)16Lowl/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2 * FVB/N) 		abnormal pituitary intermediate lobe morphology J:162892
Pgap1oto/Pgap1oto
(involves: STOCK In(1)1Rk/J) 		absent Rathke's pouch J:41878
Phf6tm1.2Avo/Y
(involves: BALB/c * BALB/cJ * C57BL/6 * FVB/N) 		small pituitary gland J:299742
Pitx1tm1Jdr/Pitx1+
Pitx2tm1Sac/Pitx2tm1Sac
(involves: 129S1/Sv * 129X1/SvJ) 		small Rathke's pouch J:73774
Pitx1tm1Jdr/Pitx1tm1Jdr
Pitx2tm1Sac/Pitx2+
(involves: 129S1/Sv * 129X1/SvJ) 		small Rathke's pouch J:73774
Pitx1tm1Jdr/Pitx1tm1Jdr
Pitx2tm1Sac/Pitx2tm1Sac
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal Rathke's pouch development J:73774
Pitx1tm1Rsd/Pitx1tm1Rsd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal pituitary gland morphology J:53310
decreased gonadotroph cell number J:53310
decreased thyrotroph cell number J:53310
Pitx2tm1.1Dmm/Pitx2tm2Sac
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6J) 		pituitary gland hypoplasia J:181058
Pitx2tm1Rsd/Pitx2tm1Rsd
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal pituitary gland development J:57673
pituitary gland hypoplasia J:57673
Pitx2tm1Sac/Pitx2tm1Sac
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal adenohypophysis morphology J:73774
absent gonadotrophs J:73774
decreased somatotroph cell number J:73774
decreased thyrotroph cell number J:73774
Pitx2tm1Sac/Pitx2tm2Sac
(involves: 129S1/Sv * 129X1/SvJ) 		small Rathke's pouch J:73774
Pitx2tm2Sac/Pitx2tm2Sac
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal adenohypophysis development J:51160
abnormal Rathke's pouch apoptosis J:99227
abnormal Rathke's pouch development J:99227, J:51160
Pitx2tm2Sac/Pitx2tm2Sac
(involves: 129S1/Sv * 129X1/SvJ) 		adenohypophysis hypoplasia J:73774
Pofut1tm2Pst/Pofut1tm1Pst
Shhtm2(cre/ERT2)Cjt/Shh+
(involves: 129/Sv * 129S6/SvEvTac * C57BL/6J * SJL) 		increased solitary pulmonary neuroendocrine cell number J:150051
Pomctm1Low/Pomc+
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6 * DBA/2) 		increased pituitary adenoma incidence J:119240
Pomctm1Low/Pomc+
Tg(Pomc)#Low/0
(involves: 129 * C57BL/6 * CBA * DBA/2 * Swiss Webster) 		increased pituitary adenoma incidence J:119240
Pomctm1Low/Pomctm1Low
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6 * DBA/2) 		increased pituitary adenoma incidence J:119240
Pomctm1Low/Pomctm1Low
Tg(Pomc)#Low/0
(involves: 129 * C57BL/6 * CBA * DBA/2 * Swiss Webster) 		increased pituitary adenoma incidence J:119240
Pou1f1dw/Pou1f1dw
(Not Specified) 		absent lactotrophs J:6754
absent somatotrophs J:7211
decreased thyrotroph cell number J:12161
Pou1f1dw/Pou1f1dw
(DW/J Pou1f1dw) 		abnormal adenohypophysis morphology J:108961
absent lactotrophs J:7211
absent somatotrophs J:7211
adenohypophysis hypoplasia J:108961
Pou2f1tm1Shrp/Pou2f1tm1Shrp
Sox2tm1.1Vep/Sox2+
(involves: 129S4/SvJae * C3H/HeN * C57BL/6) 		abnormal adenohypophysis morphology J:119175
abnormal pituitary diverticulum morphology J:119175
Pou3f2tm1Rsd/Pou3f2tm1Rsd
(involves: 129S4/SvJae * C57BL/6) 		abnormal neurohypophysis morphology J:30430
abnormal pituicyte morphology J:30430
abnormal pituitary gland morphology J:30430
Pou3f2tm1Tno/Pou3f2tm1Tno
(involves: 129S4/SvJae * C57BL/6J) 		abnormal neurohypophysis morphology J:30429
Prdm2tm1Shg/Prdm2+
(involves: 129S2/SvPas * C57BL/6) 		increased pituitary adenoma incidence J:71406
Prdm2tm1Shg/Prdm2tm1Shg
(involves: 129S2/SvPas * C57BL/6) 		increased pituitary adenoma incidence J:71406
Prkar1atm1.2Lsk/Prkar1atm1.2Lsk
Tg(Ghrhr-cre)3242Lsk/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N) 		increased pituitary gland tumor incidence J:130264
Prltm1Hmn/Prltm1Hmn
(involves: 129S2/SvPas) 		abnormal gonadotroph morphology J:79661
abnormal pituitary gland morphology J:79661
decreased lactotroph cell number J:45243
enlarged pituitary gland J:79661, J:83246
increased pituitary adenoma incidence J:79661
increased pituitary gland weight J:83246
pituitary gland hyperplasia J:79661
pituitary gland hypertrophy J:79661
Prop1df/Prop1df
(STOCK Prop1df) 		absent somatotrophs J:7211
decreased thyrotroph cell number J:12169
small adenohypophysis J:12169
Prop1df/Prop1df
(DF) 		abnormal pituitary gland development J:108961
abnormal pituitary gland morphology J:108961
pituitary gland hypoplasia J:108961
Prop1tm1Rsd/Prop1tm1Rsd
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal adenohypophysis development J:114817
Prop1tm1Sac/Prop1+
(involves: 129S1/Sv * 129S1/SvImJ * 129X1/SvJ * C57BL/6J) 		abnormal pituitary gland morphology J:94409
Prop1tm1Sac/Prop1tm1Sac
(involves: 129S1/Sv * 129S1/SvImJ * 129X1/SvJ * C57BL/6J) 		abnormal neurohypophysis morphology J:94409
adenohypophysis hypoplasia J:94409
pituitary gland hypoplasia J:94409
Psphtm1a(EUCOMM)Hmgu/Psphtm1a(EUCOMM)Hmgu
(C57BL/6N-Psphtm1a(EUCOMM)Hmgu/Wtsi) 		abnormal adenohypophysis morphology J:239583
abnormal neurohypophysis morphology J:239583
abnormal pineal gland morphology J:239583
absent neurohypophysis J:239583
absent pineal gland J:239583
Ptentm1Hwu/Ptentm1Hwu
Tg(SFTPC-rtTA)5Jaw/0
Tg(tetO-cre)1Jaw/0
(involves: 129 * 129S4/SvJae * C57BL/6 * FVB/N) 		increased solitary pulmonary neuroendocrine cell number J:146355
Ptprstm1Mtr/Ptprstm1Mtr
(involves: 129/Sv * BALB/c) 		small pituitary gland J:53434
Rab27aash/Rab27aash
Rab27btm1Tiz/Rab27btm1Tiz
(involves: 129P2/OlaHsd * C3H/He * C3H/HeSn) 		abnormal corticotroph morphology J:145238
Rag1tm1Mom/Rag1tm1Mom
Trp53tm1Brd/Trp53tm1Brd
(involves: 129S7/SvEvBrd * C57BL) 		increased pituitary adenoma incidence J:141515
Ralatm1a(EUCOMM)Wtsi/Ralatm1a(EUCOMM)Wtsi
(C57BL/6N-Ralatm1a(EUCOMM)Wtsi/Wtsi) 		multiple persisting craniopharyngeal ducts J:239583
Raratm1Ipc/Raratm1Ipc
Rargtm1Ipc/Rargtm1Ipc
(involves: 129S2/SvPas) 		abnormal pituitary gland development J:21009
Rb1tm1Brd/Rb1+
(involves: 129S7/SvEvBrd * C57BL/6) 		abnormal neuroendocrine gland morphology J:17434
increased pituitary adenoma incidence J:17434
Rb1tm1Brd/Rb1+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J) 		increased pituitary adenohypophysis tumor incidence J:79016
increased pituitary melanotroph tumor incidence J:79016
Rb1tm1Brn/Rb1+
Tg(Pomc-FLP)1aBrn/0
(involves: 129P2/OlaHsd * FVB/N) 		abnormal pituitary intermediate lobe morphology J:48860
increased pituitary adenoma incidence J:48860
Rb1tm1Brn/Rb1+
X/Tg(Pomc-FLP)1bBrn
(involves: 129P2/OlaHsd * FVB/N) 		pituitary intermediate lobe hyperplasia J:48860
Rb1tm1Brn/Rb1tm1Brn
Tg(Pomc-FLP)1aBrn/0
(involves: 129P2/OlaHsd * FVB/N) 		increased pituitary adenoma incidence J:48860
Rb1tm1Brn/Rb1tm1Brn
X/Tg(Pomc-FLP)1bBrn
(involves: 129P2/OlaHsd * FVB/N) 		increased pituitary adenoma incidence J:48860
pituitary intermediate lobe hyperplasia J:48860
Rb1tm1Mlh/Rb1+
(either: 129P2/OlaHsd-Rb1tm1Mlh or (involves: 129P2/OlaHsd * BALB/c) or (involves: 129P2/OlaHsd * FVB/N)) 		increased pituitary melanotroph tumor incidence J:20542
Rb1tm1Tyj/Rb1+
(involves: 129S2/SvPas * C57BL/6) 		increased pituitary gland tumor incidence J:81082, J:2511
Rb1tm1Tyj/Rb1+
(involves: 129S2/SvPas * C57BL/6J) 		increased pituitary adenohypophysis tumor incidence J:133299
increased pituitary melanotroph tumor incidence J:133299
Rb1tm1Tyj/Rb1+
(involves: 129S2/SvPas * 129S6/SvEvTac * FVB/N) 		increased pituitary gland tumor incidence J:175625
Rb1tm1Tyj/Rb1+
(involves: 129S2/SvPas) 		increased pituitary gland tumor incidence J:215358
Rb1tm1Tyj/Rb1+
Rbl1tm1Tyj/Rbl1+
(involves: 129S2/SvPas * C57BL/6) 		increased pituitary gland tumor incidence J:34058
Rb1tm1Tyj/Rb1+
Rbl1tm1Tyj/Rbl1tm1Tyj
(involves: 129S2/SvPas * C57BL/6) 		increased pituitary gland tumor incidence J:34058
Rb1tm1Tyj/Rb1+
Smarca4tm1Mag/Smarca4+
(involves: 129S/Sv * 129S2/SvPas * C57BL/6J * CD-1) 		increased pituitary gland tumor incidence J:132091
Rb1tm1Tyj/Rb1+
Trim27Gt(XP0484)Wtsi/Trim27Gt(XP0484)Wtsi
(involves: 129P2/OlaHsd * C57BL/6) 		increased pituitary gland tumor incidence J:189317
Rb1tm1Tyj/Rb1+
Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * C57BL/6) 		increased pituitary melanotroph tumor incidence J:19542
Rb1tm1Tyj/Rb1tm2Tyj
(chimera involves: 129S2/SvPas * C57BL/6) 		increased pituitary adenoma incidence J:59268
Rb1tm2Brn/Rb1tm2Brn
Tg(Gfap-cre)2Brn/0
(involves: 129 * FVB/N) 		increased pituitary gland tumor incidence J:187257
Rb1tm2Brn/Rb1tm2Brn
Tg(Rbp3-cre)1Brn/0
(involves: 129 * FVB/N) 		increased pituitary adenohypophysis tumor incidence J:77982
increased pituitary melanotroph tumor incidence J:77982
Rb1tm2Brn/Rb1tm2Brn
Trp53tm1Brn/Trp53tm1Brn
Tg(Gfap-cre)2Brn/0
(involves: 129 * 129P2/OlaHsd * FVB/N) 		increased pituitary gland tumor incidence J:187257
Rb1tm2Mlh/Rb1+
(either: 129P2/OlaHsd-Rb1tm2Mlh or (involves: 129P2/OlaHsd * BALB/c) or (involves: 129P2/OlaHsd * FVB/N)) 		increased pituitary melanotroph tumor incidence J:20542
Rb1tm3Tyj/Rb1tm3Tyj
Tg(Nes-cre)1Atp/0
(involves: 129S4/SvJae * FVB/N) 		increased pituitary gland tumor incidence J:91406
Rb1tm3Tyj/Rb1tm3Tyj
Trp53tm1Tyj/Trp53tm1Tyj
Tg(Nes-cre)1Atp/0
(involves: 129S2/SvPas * 129S4/SvJae * FVB/N) 		increased pituitary gland tumor incidence J:91406
Rettm2.1Cos/Ret+
(involves: 129S1/Sv * C57BL/6J * FVB/N) 		adrenergic chromaffin cell hyperplasia J:60659
Rettm2.1Cos/Rettm2.1Cos
(involves: 129S1/Sv * C57BL/6J * FVB/N) 		adrenergic chromaffin cell hyperplasia J:60659
Rfx4Tg(Myh6-CYP2J2)Tr5Dcz/Rfx4+
(involves: C57BL/6NTac) 		absent subcommissural organ J:84751
Rgsc1033/Rgsc1033+
(involves: C57BL/6JJcl * DBA/2JJcl) 		increased pituitary adenoma incidence J:133634
Rint1tm1Whl/Rint1+
(Not Specified) 		increased pituitary adenoma incidence J:122805
Rpgrip1ltm1a(EUCOMM)Wtsi/Rpgrip1ltm1a(EUCOMM)Wtsi
(C57BL/6N-Rpgrip1ltm1a(EUCOMM)Wtsi/Wtsi) 		abnormal pineal gland morphology J:239583
absent adenohypophysis J:239583
Rpgrip1ltm1Urt/Rpgrip1ltm1Urt
(involves: 129S1/Sv * 129X1/SvJ) 		absent Rathke's pouch J:123018
small Rathke's pouch J:123018
Rr115em1Bobh/Rr115+
Shhtm1Chg/Shh+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal adenohypophysis development J:306254
abnormal magnocellular neurosecretory cell morphology J:306254
abnormal neurohypophysis development J:306254
abnormal parvocellular neurosecretory cell morphology J:306254
abnormal Rathke's pouch development J:306254
ectopic neurohypophysis J:306254
Scg5tm1Led/Scg5tm1Led
(either: 129S6/SvEvTac or (involves: 129S6/SvEvTac * FVB) or (involves: 129S6/SvEvTac * C57BL/6)) 		small adenohypophysis J:77510
Sdhdtm1Jlob/Sdhdtm2Jlob
Thtm1(cre)Te/Th+
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal adrenal chromaffin cell morphology J:186713
Sema3atm1.1Tyag/Sema3atm1.1Tyag
Vegfatm1Pec/Vegfatm1Pec
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6NCrlj * CBA/JNCrlj) 		decreased gonadotropin-releasing hormone neuron number J:175836
Serp1tm1Hori/Serp1tm1Hori
(involves: 129X1/SvJ * C57BL/6) 		small adenohypophysis J:109619
small pituitary gland J:109619
Setd5tm1a(EUCOMM)Wtsi/Setd5+
(C57BL/6N-Setd5tm1a(EUCOMM)Wtsi/Wtsi) 		abnormal pineal gland morphology J:239583
Sh2d3ctm1.1Ebp/Sh2d3ctm1.1Ebp
(involves: C57BL/6) 		decreased gonadotropin-releasing hormone neuron number J:164874
Sh3pxd2atm1b(EUCOMM)Wtsi/Sh3pxd2atm1b(EUCOMM)Wtsi
(C57BL/6N-Sh3pxd2atm1b(EUCOMM)Wtsi/Wtsi) 		abnormal adenohypophysis morphology J:239583
abnormal pineal gland morphology J:239583
Sim1tm1Fan/Sim1tm1Fan
(involves: 129/Sv * C57BL/6) 		abnormal pituicyte morphology J:50772
absent magnocellular neurosecretory cells J:50772
pituitary gland hypoplasia J:50772
Sirt1tm3Fwa/Sirt1tm3Fwa
Tg(Nes-cre)1Kln/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL) 		decreased pituitary gland weight J:155802
small pituitary gland J:155802
Six1tm1Rsd/Six1tm1Rsd
(involves: 129S1/Sv * 129X1/SvJ) 		small adenohypophysis J:86619
Six6tm1Rsd/Six6tm1Rsd
(either: 129 or (involves: 129S1/Sv * 129X1/SvJ)) 		pituitary gland hypoplasia J:104339
Six6tm1Rsd/Six6tm1Rsd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal gonadotropin-releasing hormone neuron morphology J:168233
decreased gonadotropin-releasing hormone neuron number J:168233
Slc6a3tm1Mca/Slc6a3tm1Mca
(involves: 129P2/OlaHsd) 		abnormal adenohypophysis morphology J:41856
adenohypophysis hypoplasia J:41856
decreased lactotroph cell number J:41856
decreased somatotroph cell number J:41856
pituitary intermediate lobe hypoplasia J:41856
Slc6a3tm1Mca/Slc6a3tm1Mca
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal adenohypophysis morphology J:93114
small pituitary gland J:93114
Slc6a3tm1Mca/Slc6a3tm1Mca
Slc6a4tm1Kpl/Slc6a4tm1Kpl
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal adenohypophysis morphology J:93114
small pituitary gland J:93114
Slc20a2tm1a(EUCOMM)Wtsi/Slc20a2tm1a(EUCOMM)Wtsi
(C57BL/6N-Slc20a2tm1a(EUCOMM)Wtsi/Wtsi) 		multiple persisting craniopharyngeal ducts J:239583
Slc23a2tm1Nbm/Slc23a2tm1Nbm
(129S6/SvEvTac-Slc23a2tm1Nbm) 		abnormal adrenergic chromaffin cell morphology J:85988
Slc25a20tm1a(EUCOMM)Wtsi/Slc25a20tm1a(EUCOMM)Wtsi
(C57BL/6N-Slc25a20tm1a(EUCOMM)Wtsi/Wtsi) 		multiple persisting craniopharyngeal ducts J:239583
Smg9tm1b(EUCOMM)Wtsi/Smg9tm1b(EUCOMM)Wtsi
(C57BL/6N-Smg9tm1b(EUCOMM)Wtsi/Wtsi) 		abnormal neurohypophysis morphology J:239583
abnormal pineal gland morphology J:239583
Smpd3tm1Wst/Smpd3tm1Wst
(involves: 129S1/Sv) 		abnormal adenohypophysis morphology J:97284
abnormal pituicyte morphology J:97284
decreased corticotroph cell number J:97284
decreased gonadotroph cell number J:97284
decreased somatotroph cell number J:97284
decreased thyrotroph cell number J:97284
Socs7tm1Wsa/Socs7tm1Wsa
(involves: C57BL/6) 		abnormal subcommissural organ morphology J:93449
Sox2tm1Rlb/Sox2+
(involves: 129S/SvEv * MF1) 		abnormal adenohypophysis development J:114458
abnormal pituitary gland morphology J:114458
bifurcated Rathke's pouch J:114458
decreased somatotroph cell number J:114458
small adenohypophysis J:114458
Sox3tm1Pqt/Y
(chimera involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2) 		abnormal adenohypophysis development J:195300
abnormal pituitary infundibular stalk morphology J:195300
absent pituitary infundibular stalk J:195300
Sox3tm1Rlb/Y
(involves: 129S7/SvEvBrd * MF1) 		abnormal pituitary gland morphology J:88507
abnormal Rathke's pouch development J:88507
bifurcated Rathke's pouch J:88507
Sox3tm1Rlb/Sox3tm1Rlb
(involves: 129S7/SvEvBrd * MF1) 		abnormal pituitary gland morphology J:88507
abnormal Rathke's pouch development J:88507
bifurcated Rathke's pouch J:88507
Stx1btm1.1Sud/Stx1btm1.1Sud
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal adrenal chromaffin cell morphology J:138035
Sytl4tm1Tiz/Y
(involves: 129P2/OlaHsd) 		abnormal corticotroph morphology J:145238
tb/tb
(Not Specified) 		absent lactotrophs J:12166
pituitary gland hyperplasia J:12166
Tbx19tm1Jdr/Tbx19tm1Jdr
(either: (involves: 129/Sv) or (involves: BALB/c)) 		decreased corticotroph cell number J:82562
Tcf7l2tm1a(EUCOMM)Wtsi/Tcf7l2tm1a(EUCOMM)Wtsi
(C57BL/6N-Tcf7l2tm1a(EUCOMM)Wtsi/Wtsi) 		abnormal neurohypophysis morphology J:239583
Tcf7l2tm1Cle/Tcf7l2tm1Cle
(involves: 129P2/OlaHsd) 		abnormal pituitary intermediate lobe morphology J:86317
enlarged adenohypophysis J:86317
enlarged pituitary gland J:86317
Tcof1tm1Mjd/Tcof1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal Rathke's pouch development J:62928
Tg(AMH-Fshr*D580H)#Hht/0
(involves: FVB/N) 		increased pituitary gland weight J:160015
increased prolactinoma incidence J:160015
pituitary gland hyperplasia J:160015
Tg(CAG-Ncoa6)71Hwl/0
(involves: FVB) 		abnormal pituitary gland morphology J:80609
Tg(CAG-Ncoa6)87Hwl/0
(involves: FVB) 		abnormal pituitary gland morphology J:80609
Tg(CAG-Ncoa6)104Hwl/0
(involves: FVB) 		abnormal pituitary gland morphology J:80609
Tg(Gh1-rtTA)4-3Jek/0
Tg(tetO-Egfr*)2-9Jek/0
(involves: C57BL/6 * SJL) 		abnormal gonadotroph morphology J:68692
decreased lactotroph cell number J:68692
decreased somatotroph cell number J:68692
small adenohypophysis J:68692
Tg(Gh-Gal)4599Vron/?
(involves: C57BL/6 * CD-1 * SJL) 		increased pituitary adenoma incidence J:86486
pituitary gland hyperplasia J:86486
Tg(Gnrh1-Fgfr1)1Tsai/Tg(Gnrh1-Fgfr1)1Tsai
(involves: C57BL/6J * DBA/2J) 		abnormal gonadotropin-releasing hormone neuron morphology J:95057
decreased gonadotropin-releasing hormone neuron number J:95057
Tg(Mdm2)1Snj/0
(involves: 129S7/SvEvBrd * C57BL/6) 		increased pituitary adenoma incidence J:51661
Tg(MMTV-NCOA3)#Mybr/0
(FVB/N-Tg(MMTV-NCOA3)#Mybr) 		increased pituitary adenoma incidence J:93548
Tg(Prl-EGFR)#Sme/0
(Not Specified) 		increased prolactinoma incidence J:219654
Tg(PyLT)1Vb/0
(Not Specified) 		increased pituitary adenoma incidence J:55528
increased pituitary gland tumor incidence J:55528
Tg(Rbp3-SV40)IT-2Jjw/?
(involves: BALB/c * C57BL/6) 		enlarged pineal gland J:60231
increased pineal gland tumor incidence J:60231
Tg(Sox3)1Pqt/0
Tg(Sox3-EGFP)NrPqt/0
(involves: C57BL/6 * CBA) 		abnormal subcommissural organ morphology J:184232
absent pineal gland J:184232
Tg(Sox3-EGFP)NrPqt/0
(involves: C57BL/6 * CBA) 		abnormal subcommissural organ morphology J:184232
Tg(TG-RET/CCDC6)42Cled/0
(involves: FVB/N) 		increased thyrotroph cell number J:93679
increased thyrotroph cell size J:93679
Thratm1Ven/Thratm1Ven
Thrbtm1Df/Thrbtm1Df
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6) 		small pituitary gland J:95391
Thrbtm1.1Syc/Thrbtm1.1Syc
(involves: 129S6/SvEvTac * FVB/N * NIH Black Swiss) 		increased thyrotroph cell number J:65885
Thrbtm1.1Syc/Thrbtm1.1Syc
(involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6) 		enlarged pituitary gland J:95391
increased pituitary adenoma incidence J:95391
Thrbtm3Few/Thrbtm3Few
(involves: 129 * C57BL/6) 		increased thyrotroph cell number J:85158
Thrbtm4Few/Thrbtm4Few
(involves: 129 * C57BL/6) 		increased thyrotroph cell number J:85158
Tle5tm1Grid/Tle5tm1Grid
(involves: 129S1/Sv * C57BL/6J) 		abnormal pituitary diverticulum morphology J:86317
abnormal pituitary gland morphology J:86317
bifurcated Rathke's pouch J:86317
enlarged pituitary gland J:86317
Tpst2grt/Tpst2grt
(involves: DW/JMuaf) 		abnormal adenohypophysis morphology J:20343
enlarged adenohypophysis J:20343
Tpx2Gt(D028B03)Wrst/Tpx2+
(involves: 129S2/SvPas * C57BL/6J) 		pituitary intermediate lobe hyperplasia J:184948
Traf6tm2a(EUCOMM)Wtsi/Traf6tm2a(EUCOMM)Wtsi
(C57BL/6N-Traf6tm2a(EUCOMM)Wtsi/Wtsi) 		multiple persisting craniopharyngeal ducts J:239583
Trappc9tm1a(EUCOMM)Wtsi/Trappc9tm1a(EUCOMM)Wtsi
(C57BL/6N-Trappc9tm1a(EUCOMM)Wtsi/Wtsi) 		multiple persisting craniopharyngeal ducts J:239583
Trhtm1Mmt/Trhtm1Mmt
(involves: C57BL/6 * CBA) 		abnormal pituitary gland development J:59141
Trhtm1Mmt/Trhtm1Mmt
(involves: C57BL/6 * CBA * ICR) 		abnormal pituitary gland development J:43657
Trp53bp2tm1Xlu/Trp53bp2tm1Xlu
(C.129S6-Trp53bp2tm1Xlu) 		abnormal pineal gland morphology J:240594
absent pineal gland J:240594
Trp73tm1(cre)Agof/Trp73tm1(cre)Agof
(involves: 129S1/Sv * 129X1/SvJ) 		decreased gonadotropin-releasing hormone neuron number J:153209
Tshrhyt-2J/Tshrhyt-2J
(B6;129P3-Tshrhyt-2J/GrsrJ) 		increased thyrotroph cell number J:213054
Vamp2tm1Sud/Vamp2tm1Sud
(involves: 129P2/OlaHsd) 		abnormal adrenal chromaffin cell morphology J:138035
Vax1tm1Pgr/Vax1tm1Pgr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal pituitary gland morphology J:257247
Vegfatm1Pec/Vegfatm1Pec
(involves: 129S1/Sv * 129X1/SvJ) 		decreased gonadotropin-releasing hormone neuron number J:175836
Vgftm1Vlcg/Vgftm1Vlcg
(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NTac) 		abnormal noradrenergic chromaffin cell morphology J:212045
Wdr11Gt(Ayu21-KBW205)Imeg/Wdr11Gt(Ayu21-KBW205)Imeg
(B6.Cg-Wdr11Gt(Ayu21-KBW205)Imeg) 		abnormal adenohypophysis morphology J:257035
abnormal neurohypophysis median eminence morphology J:257035
abnormal pituitary diverticulum morphology J:257035
abnormal pituitary gland development J:257035
decreased gonadotropin-releasing hormone neuron number J:257035
Rathke's pouch hypoplasia J:257035
Wnt4tm1Amc/Wnt4tm1Amc
(involves: 129/Sv * CD-1) 		abnormal adenohypophysis morphology J:48144
decreased gonadotroph cell number J:48144
decreased somatotroph cell number J:48144
decreased thyrotroph cell number J:48144
Wwoxtm1Ria/Wwoxtm1Ria
(involves: 129X1/SvJ * C57BL/6J) 		increased pituitary gland weight J:138140
Zfp521tm1Nohk/Zfp521tm1Nohk
(B6J.Cg-Zfp521tm1Nohk) 		decreased pituitary gland weight J:214267
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
12/10/2024
MGI 6.24 		The Jackson Laboratory